 | Atea Pharmaceuticals, Inc. | |||
| NMS : AVIR || Location: United States | ||||
$3.7-0.03 (-0.8%) |
0.2 M | 3.68 - 3.73 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.666 M |
| March 15, 2024 | 1.700 M |
| Feb. 29, 2024 | 1.646 M |
| Feb. 15, 2024 | 1.622 M |
| Jan. 31, 2024 | 3.796 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.51 | -0.47 | 7.22% |
| 09/30/2023 | -0.49 | -0.40 | 17.73% |
| 06/30/2023 | -0.48 | -0.34 | 29.08% |
| 03/31/2023 | -0.49 | -0.43 | 11.72% |
| 12/31/2022 | -0.46 | -0.41 | 10.68% |
AVIR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 84.164M | Shares Float | 63.737M |
| Short Float | 1.666M | Market Cap | 313.93M |
| Institution ownership | 67.50% | Insider ownership | 9.464% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.63 | Forward EPS | -2.92 |